Elisa Uliassi

Title: Elisa Uliassi: Innovator in P2Y Receptor Antagonism

Introduction

Elisa Uliassi is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as antagonists of the P2Y receptor. Her work is crucial in addressing various health disorders.

Latest Patents

Elisa Uliassi holds a patent for "Triazole derivatives as P2Y receptor antagonists." This patent describes compounds that serve as antagonists of the P2Y receptor, including a specific compound of formula (I) with defined characteristics. The patent also details dendron conjugates that incorporate these compounds and outlines methods for utilizing them in treating disorders such as inflammation, diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, metabolic syndrome, and asthma. Additionally, it includes methods for antagonizing P2Y receptor activity in cells.

Career Highlights

Elisa Uliassi is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in groundbreaking research and innovation in the medical field.

Collaborations

Elisa has collaborated with notable colleagues, including Kenneth Alan Jacobson and Anna Junker. These partnerships enhance her research efforts and contribute to the advancement of her work.

Conclusion

Elisa Uliassi is a distinguished inventor whose work on P2Y receptor antagonists has the potential to impact the treatment of various health conditions. Her contributions to pharmacology and her collaborations with esteemed colleagues underscore her importance in the field.